Ruboxistaurin mesylate monohydrate, CAS [[202260-21-7]]

Produktübersicht

• Artikelname: Ruboxistaurin mesylate monohydrate, CAS [[202260-21-7]]
• Artikelnummer: TGM-T69990
• Hersteller Artikelnummer: T69990
• Alternativnummer: TGM-T69990-25MG,TGM-T69990-50MG,TGM-T69990-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Ruboxistaurin mesylate monohydrate is a PKC beta inhibitor potentially for the treatment of diabetic nephropathy and diabetic macular edema. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-beta1/Smad and GRAP pathways. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.

Produkteigenschaften

• Molekulargewicht: 582.67
• CAS Nummer: [202260-21-7]
• Formel: C29H34N4O7S
• Target-Kategorie: Others

Bilder

T69990